| |
|
ABSTRACT |
SLIDES |
|
| 08:00 |
Registration (Tea & Coffee) |
|
|
|
| 08:30 |
Welcome/Opening |
|
|
Dominic Hodgson / Cdre Paul Pitcher |
|
Invited Speakers |
|
|
Chair: Yoodhvir Nagar / Wojciech Polak |
| 08:45 |
Preliminary results of LIBERATE – focal brachytherapy for low-to intermediate risk prostate cancer: QOL and early oncological outcomes |
|
|
Andrew See, Icon Group, Australia |
| 09:10 |
Update on Prostate Brachytherapy Guidelines from the EAU |
|
 |
Philip Cornford, Royal Liverpool and Broadgreen University Hospitals |
| 09:35 |
Brachytherapy with SpaceOAR |
|
 |
Roberto Alonzi, Mount Vernon |
| 10:00 |
One-minute Poster Pitches |
|
|
Chair: Tony Palmer |
| |
Outcomes for patients with prostate cancer treated with External beam radiotherapy with High dose rate brachytherapy (HDR) boost at the Dorset Cancer Centre |
 |
|
Aun-Kyaw Sun, Ben Masters |
| |
Comparison of pre and post implant LUTS with implant dosimetry to determine cause of increase in post implant complications |
 |
|
Sara Hodkinson, Jennifer Beeby, Ben Medford |
| |
Development of a commissioning protocol for micro silica bead thermo-luminescent dosimeters (TLDs) for use in high dose rate brachytherapy. |
 |
|
William Hamblyn, Amani Chowdhury, Gerry Lowe, Peter Hoskin |
| |
The impact of needle reconstruction uncertainties on TRUS prostate plan parameters |
 |
|
Jennifer Wilson |
| |
RTT-led follow-up using patient-reported outcome measures following HDR-brachytherapy for prostate cancer |
 |
|
Sarah Stead, Lauren Oliver, Richard Walshaw, Chinnamani Eswar, Isabel Syndikus, R Hunter |
| |
Development of a self TWOC service for out Brachytherapy service. |
 |
|
Claire Johnson, Alice Gamble |
| |
A Quality Improvement Project for prescribing for local anaesthetic trans-perineal prostate biopsies: outcomes from 944 patients. |
 |
|
Tomas Austin, Joshuah Hill, Sean Pellow, Sally Deverill, Matt Crockett, Dominic Hodgson |
| |
A 3D Printed Phantom for Training in Ultrasound Guided Prostate Brachytherapy |
 |
|
Siobhan Gorman, Sreelish Kariyarambath, Peter Gribbin |
| |
Environmental Sustainability in Brachytherapy: A UK study |
 |
|
Gerry Lowe, Amanda Tate, Priya Narga‑Martin |
| |
MRI registration with the Transrectal ultrasound in LDR Prostate Brachytherapy |
 |
|
Prabakar Sukumar, Helen Winter |
| |
Comparative analysis of pre-operative LDR Treatment Planning based on MRI and US prostate volume studies |
 |
|
Inna O’Hea, Wojciech Polak, Sarah Wilby, Harry Gibbard |
| |
Development of a Prostate Tissue Mimicking Material and Reusable Phantom for MRI Biopsy and Brachytherapy |
 |
|
Sarah Wilby, Antony Palmer, Wojciech Polak |
| |
Possibility of salvage re-irradiation of perineal prostate cancer nodule following prostate low dose rate brachytherapy (LDR-BT). |
 |
|
Mark Long |
| |
An analysis of LDR prostate brachytherapy outcomes in a single centre over 18 years |
 |
|
Bowen J, Mirza S, Al-Eryani K, Berman B, O’Hea I, Hodgson D |
| 10:15 |
Tea & Coffee/Exhibition and Poster Viewing |
|
Proffered Presentations |
|
|
Chair: Peter Hoskin/ Ann Henry |
| 10:45 |
Can low dose rate brachytherapy be considered a treatment option for patients with prostate cancer with intermediate or high risk features? |
 |
 |
Rebecca Morgan, Poole General Hospital |
| 10:55 |
QOL outcomes in patients receiving Low dose rate brachytherapy boost with EBRT for unfavourable intermediate and high risk prostate cancer: A single institution experience. |
 |
 |
Mansoor Qayoumi, Cork University Hospital |
| 11:05 |
Analysis of Survival Following Low-Dose Rate Brachytherapy Boost for Prostate Cancer at the Royal Surrey Hospital: A Comparison with the Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (ASCENDE-RT) Trial |
 |
 |
Metawe Mohamed, Royal Surrey Hospital |
| 11:15 |
HDR brachytherapy boost in Gleason 9-10 prostate cancer |
 |
 |
Heather Tovey, University Hospital of Leicester |
| 11:25 |
High dose-rate salvage brachytherapy in prostate cancer with isolated seminal vesicle relapse |
 |
|
Milan Anjanappa, Mount Vernon |
| 11:35 |
Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility Study Investigating Toxicity Outcomes Following Reirradiation with Stereotactic Body Radiotherapy (SBRT) vs. High Dose-Rate Brachytherapy (HDR-BT) |
 |
 |
Jim Zhong, Leeds Cancer Centre |
| 11:45 |
Using ProKnow to set up an inter Trust database of post implant dosimetry for prostate iodine-125 implants. |
 |
 |
Daniel Emmens, Maidstone & Tunbridge Wells |
| 12:00 |
Lunch/Exhibition and Poster Viewing |
|
|
|
|
Debate |
|
|
Chair: Philip Cornford / Yoodhvir Nagar |
| 13:00 |
SABR vs LDR brachytherapy |
|
 |
Julia Murray, Royal Marden, Ann Henry, Leeds Cancer Centre |
|
Proffered Presentations |
|
|
Chair: Dominic Hodgson / Sarah Wilby |
| 13:45 |
Commissioning for HDR prostate Brachytherapy: Early Clinical Experience |
 |
 |
Rissa Cunningham, Guy’s and St. Thomas’ |
| 13:55 |
MRI-guided Needle Placement Robot for Prostate Brachytherapy |
 |
|
Taimur Shah, Imperial College London |
| 14:05 |
Innovative Approaches to Prostate Biopsy Decision-Making: A Machine Learning and Optimisation Framework |
 |
 |
Sara Saadatmand, University of Portsmouth |
| 14:15 |
Predictive factors in US-MRI fusion prostate biopsy: a review of 2347 case. |
 |
 |
Harry Gibbard, Portsmouth |
| 14:25 |
Tea & Coffee/Exhibition and Poster Viewing |
|
Invited Speakers |
|
|
Chair: Dominic Hodgson / Tony Palmer |
| 14:55 |
ORIGIN: Optical fibre sensors for in vivo dosimetry |
|
 |
Sinead O’Keefe, University of Limerick |
| 15:20 |
Salvage brachytherapy: do we have consensus? |
|
 |
Peter Hoskins, Mount Vernon & Christie Cancer Centre |
| 15:45 |
Update on Prostate Biopsy Guidelines from the EAU |
|
 |
Philip Cornford, Royal Liverpool and Broadgreen University Hospitals |
| 16:00 |
Drug Loaded Spacers for LDR Prostate Brachytherapy |
|
 |
Andrew Wang, UT Southwestern Medical Centre |
| 16:25 |
Meeting Close and Handover |
|
|
Dominic Hodgson |